Will Morton[email protected]Molecular ImagingImmuno-PET/CT detects myeloma missed by FDG-PET/CTStandard FDG PET/CT misses active multiple myeloma in 30% to 50% of patients with biopsy-proven disease.November 3, 2026MRIMRI, PET reveal distinct brain changes in loneliness and social isolationPrior studies frequently have used the terms interchangeably and applied measures designed for one construct when investigating the other.October 28, 2026CTLDCT predicts vertebral fracture risk in heavy smokersParticipants were heavy smokers aged 55 to 74 years old with at least 30 pack-years of smoking history.October 27, 2026Digital X-RayChatGPT-5 misses half of distal radius fractures on x-raysChatGPT-5 missed 83 fractures, demonstrating a sensitivity of 51.2% and a specificity of 70.5%, with overall accuracy of 61.6%.October 27, 2026CTPilot project triples LDCT ordering among Hispanic patientsHispanic patients face persistent barriers to lung cancer screening, and culturally adapted multilevel interventions remain an underexplored approach.October 22, 2026Nuclear MedicineEANM: Is ‘research fragmentation’ holding back nuclear medicine?Well-designed studies require collaboration among nuclear medicine, medical oncology, urology, radiation oncology, and clinical trial support.October 21, 2026Nuclear MedicineEANM: Thomas Hope on what’s next in FAP-targeted theranosticsThe innovations and work being done to optimize FAP agents will likely "spill over" to other targets.October 19, 2026InterventionalGAE cuts steroid injections by half in knee osteoarthritis patientsSteroid injections provide only short-term relief, and repeated use carries concern for further cartilage damage.October 14, 2026Molecular ImagingAuntMinnie.com Molecular Imaging InsiderWe’ve highlighted a secondary analysis of the LUNAR trial, with findings suggesting the benefits of lutetium-177 (Lu-177) PNT200 extend to more clinically meaningful disease states.October 13, 2026Nuclear MedicineLu-177 PNT2002 before SBRT extends disease control in prostate cancerA group from the University of California, Los Angeles, updated an analysis of outcomes from the LUNAR trial by 10 months.October 13, 2026Previous PagePage 2 of 61Next PageTop StoriesMolecular ImagingAppropriate use criteria issued for FET-PET brain imagingThe workgroup rated FET PET as “appropriate” in two scenarios.UltrasoundUltrasound MinnieCast, Episode 20: Explorations in ultrasound AIWomen’s Imaging PreviewRoad to RSNA 2026: Women's Imaging PreviewAIDaily AI use high among radiologists, may help hone skillsMolecular ImagingSPECT-guided algorithm can aid in assessing Lu-177 RPT responses